87 related articles for article (PubMed ID: 6809831)
1. Radioimmunoassay for an analog of thyrotrophin-releasing hormone, gamma-butyrolactone-gamma-carbonyl-L-histidyl-L-prolinamide (DN-1417).
Shiota K; Miyake A; Tsunoda C; Oka Y; Nagawa Y; Nakayama R
J Immunol Methods; 1982; 51(1):69-80. PubMed ID: 6809831
[TBL] [Abstract][Full Text] [Related]
2. Kinetic study on disappearance of gamma-butyrolactone-gamma-carbonyl-L-histidyl-L-prolinamide (DN-1417) from plasma using a radioimmunoassay for DN-1417 isobutylamide.
Oshima I; Saito S; Shiota K; Miyake A; Oka Y; Nakayama R
J Pharmacobiodyn; 1983 Mar; 6(3):202-8. PubMed ID: 6410041
[TBL] [Abstract][Full Text] [Related]
3. Absorption of gamma-butyrolactone-gamma-carbonyl-L-histidyl-L-prolinamide citrate (DN-1417), an analog of thyrotropin-releasing hormone, in rats and dogs.
Yokohama S; Yoshioka T; Kitamori N
J Pharmacobiodyn; 1984 Aug; 7(8):527-35. PubMed ID: 6439851
[TBL] [Abstract][Full Text] [Related]
4. Intestinal absorption mechanisms of gamma-butyrolactone-gamma-carbonyl-L-histidyl-L-prolinamide citrate (DN-1417) and thyrotropin-releasing hormone (TRH).
Yokohama S; Yoshioka T; Kitamori N; Shimamoto T; Kamada A
J Pharmacobiodyn; 1985 Apr; 8(4):278-85. PubMed ID: 3928869
[TBL] [Abstract][Full Text] [Related]
5. [A TRH analog (DN-1417). Blood level and brain distribution determined by radioimmunoassay after intravenous administration in rats].
Nagai Y; Narumi S; Saji Y; Nagawa Y
Nihon Yakurigaku Zasshi; 1985 Apr; 85(4):231-42. PubMed ID: 3924797
[TBL] [Abstract][Full Text] [Related]
6. Intracerebroventricular injection of a TRH analogue, gamma-butyrolactone-gamma-carbonyl-L-histidyl-prolinamide, induces gastric lesions and gastric acid stimulation in rats.
Maeda-Hagiwara M; Watanabe H
Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):142-6. PubMed ID: 3930976
[TBL] [Abstract][Full Text] [Related]
7. In vitro thyrotrophin release with thyrotropin-releasing hormone and an analogue, DN-1417.
Shiota K; Yoshida K; Noguchi C; Nakayama R
Acta Endocrinol (Copenh); 1984 May; 106(1):71-8. PubMed ID: 6428117
[TBL] [Abstract][Full Text] [Related]
8. Increase in rat regional brain cyclic nucleotides by thyrotropin-releasing hormone (TRH) and its analog DN-1417.
Narumi S; Nagai Y; Saji Y; Nagawa Y
Jpn J Pharmacol; 1983 Oct; 33(5):915-26. PubMed ID: 6139495
[TBL] [Abstract][Full Text] [Related]
9. Determination of L-6-keto-piperidine-2-carbonyl-L-leucyl-L-proline amide (RGH-2202), a new analog of thyrotropin-releasing hormone, in plasma by radioimmunoassay.
Terauchi Y; Ishikawa S; Oida S; Negoro T; Kagemoto A; Sekine Y
J Pharmacobiodyn; 1988 Jun; 11(6):459-64. PubMed ID: 3139860
[TBL] [Abstract][Full Text] [Related]
10. Effects of thyrotropin releasing hormone and its analogue, DN 1417, on biopterin concentration and tryptophan hydroxylation in rat raphe slices.
Sawada M; Hirata Y; Minami M; Nagatsu T
Life Sci; 1987 Dec; 41(25):2733-7. PubMed ID: 3121968
[TBL] [Abstract][Full Text] [Related]
11. Gamma-butyrolactone-gamma-carbonyl-histidyl-prolinamide citrate (DN-1417): a novel TRH analog with potent effects on the central nervous system.
Miyamoto M; Fukuda N; Narumi S; Nagai Y; Saji Y; Nagawa Y
Life Sci; 1981 Feb; 28(8):861-9. PubMed ID: 6783804
[No Abstract] [Full Text] [Related]
12. Antiepileptic effects of thyrotropin-releasing hormone and its new derivative, DN-1417, examined in feline amygdaloid kindling preparation.
Sato M; Morimoto K; Wada JA
Epilepsia; 1984 Oct; 25(5):537-44. PubMed ID: 6434294
[TBL] [Abstract][Full Text] [Related]
13. A radioimmunoassay for TA-0910, a new metabolically stable thyrotrophin-releasing hormone analogue.
Chishima S
J Pharm Biomed Anal; 1994 Jun; 12(6):795-804. PubMed ID: 7918782
[TBL] [Abstract][Full Text] [Related]
14. A TRH analog (DN-1417): effects on local cerebral glucose utilization in conscious and pentobarbitalized rats determined by the autoradiographic 2-deoxy-[14C]glucose method.
Nagai Y; Narumi S; Miyamoto M; Saji Y; Nagawa Y
Jpn J Pharmacol; 1983 Jun; 33(3):635-45. PubMed ID: 6413736
[TBL] [Abstract][Full Text] [Related]
15. Thyrotropin-releasing hormone (TRH) and its analog (DN-1417): interaction with pentobarbital in oxygen consumption and cyclic AMP formation of rat cerebral cortex slices.
Narumi S; Nagai Y; Saji Y; Nagawa Y
Life Sci; 1984 May; 34(22):2177-84. PubMed ID: 6328158
[TBL] [Abstract][Full Text] [Related]
16. Effect of DN-1417, a thyrotropin releasing hormone analog, on dopaminergic neurons in rat brain.
Nakahara T; Matsumoto T; Hirano M; Uchimura H; Yokoo H; Nakamura K; Ishibashi K; Hirano H
Peptides; 1985; 6(6):1093-9. PubMed ID: 3938840
[TBL] [Abstract][Full Text] [Related]
17. Effects of thyrotropin releasing hormone and its analogues on unconsciousness following head injury in mice.
Tanaka K; Ogawa N; Chou H; Mori A; Yanaihara N
Regul Pept; 1992 Mar; 38(2):129-33. PubMed ID: 1574607
[TBL] [Abstract][Full Text] [Related]
18. Potential anti-depressive effects of thyrotropin releasing hormone (TRH) and its analogues.
Ogawa N; Mizuno S; Mori A; Nukina I; Ota Z; Yamamoto M
Peptides; 1984; 5(4):743-6. PubMed ID: 6436797
[TBL] [Abstract][Full Text] [Related]
19. [A TRH analog (DN-1417). Antagonistic effects on reserpine-induced decreases in local cerebral glucose utilization and cerebral monoamine levels].
Nagai Y; Narumi S; Saji Y; Nagawa Y
Nihon Yakurigaku Zasshi; 1985 May; 85(5):315-26. PubMed ID: 3928465
[TBL] [Abstract][Full Text] [Related]
20. [TRH and its analog (DN-1417). Effects on central dopaminergic system-dependent behaviors in rats and mice].
Miyamoto M; Saji Y; Nagawa Y
Nihon Yakurigaku Zasshi; 1985 Mar; 85(3):129-41. PubMed ID: 3924793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
